National Asthma Council and federal government release new guidelines overhauling the way asthma is treated

New guidelines that seek to change how asthma is treated in Australia have been unveiled by Health Minister Mark Butler and ...

Australian doctors advised to stop prescribing blue puffer to treat asthma for some patients

Australia has overhauled the way asthma is treated, with doctors advised to stop prescribing blue “reliever” puffers alone ...
body+soul

Advice for treating asthma is changing – here's what you need to know

The National Asthma Council’s advice for treating the condition has been updated, advising doctors against solely prescribing blue puffers to patients.
Clinical Advisor

Post Asthma Exacerbation, Better Therapy Adherence Is Rare and Fleeting

Researchers assessed whether having a severe asthma exacerbation affected patients’ ICS therapy adherence in a way that improved future exacerbation outcomes.

Dr Zoe's asthma clinic: Do I have the right inhaler?

With new NHS guidelines causing confusion amongst inhaler users, Dr Zoe is helping to explain what’s changed and why, and ...
Medscape

NICE: No More Blue Inhaler Only for New Asthma Diagnoses

GPs have been advised to stop prescribing blue reliever inhalers alone for newly-diagnosed asthma. Instead, they should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to ...
Healio

FDA updates Airsupra prescribing information to include benefit in mild asthma

The FDA has updated the prescribing information for Airsupra, a fixed dose of albuterol and budesonide, to include that it ...
Medscape

Obesity and Metabolic Factors Linked to Higher Risk for Asthma

The prevalence of asthma is high among US adults with obesity or hypertension, with each condition associated with elevated asthma risk and their combination heightening it further.